Community-guided, autism-adapted group cognitive behavioral therapy for depression in autistic youth (CBT-DAY): Preliminary feasibility, acceptability, and efficacy
Autism · 2024-08 · 28 (8) · 1902-1918
DOI: 10.1177/13623613231213543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Autism, online erschienen am 27.11.2023. Verfasst von Jessica M Schwartzman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, USA. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Feasibility Studies, Psychotherapy, Group, Depression. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, NIMH NIH HHS, NIDCD NIH HHS.
Themen: Depression
Abstract (Originalsprache)
This study examined the preliminary feasibility, acceptability, and efficacy of an autism-adapted cognitive behavioral therapy for depression in autistic youth, CBT-DAY. Twenty-four autistic youth (11–17 years old) participated in the pilot non-randomized trial including 5 cisgender females, 14 cisgender males, and 5 non-binary youth. Youth participated in 12 weeks of, CBT-DAY and youth depressive symptoms (i.e., primary clinical outcome) and emotional reactivity and self-esteem (i.e., intervention mechanisms) were assessed through self-report and caregiver report at four timepoints: baseline (week 0), midpoint (week 6), post-treatment (week 12), and follow-up (week 24). Results suggested that CBT-DAY may be feasible (16.67% attrition) in an outpatient setting and acceptable to adolescents and their caregivers. Bayesian linear mixed-effects models showed that CBT-DAY may be efficacious in targeting emotional reactivity [β T1-T3 = −2.53, CrI 95% (−4.62, −0.58), P d = 0.995, d = −0.35] and self-esteem [β T1-T3 = −3.57, CrI 95% (−5.17, −2.00), P d > 0.999, d = −0.47], as well as youth depressive symptom severity [β = −2.72, CrI 95% (−3.85, −1.63), P d > 0.999]. Treatment gains were maintained at follow-up. A cognitive behavioral group therapy designed for and with autistic people demonstrates promise in targeting emotional reactivity and self-esteem to improve depressive symptom severity in youth. Findings can be leveraged to implement larger, more controlled trials of CBT-DAY. The trial was registered at Clinicaltrials.gov (Identifier: NCT05430022; https://beta.clinicaltrials.gov/study/NCT05430022 ). Lay Abstract Depression in youth is a significant public health problem worldwide, particularly for autistic youth who are over twice as likely to experience depression than their non-autistic peers. Although pathways to depression are complex, emotional reactivity and negative self-esteem are two risk factors for depression in autistic and non-autistic youth. Although autistic youth are more likely to experience depression than their non-autistic peers, psychotherapy options for autistic youth are very limited; community guidance in the development and testing of psychotherapy programs is a promising approach in autism. Therefore, in this study, we designed an autism-adapted CBT-DAY, in collaboration with autistic community members. Specifically, CBT-DAY combined neurodiversity-affirming and cognitive behavioral approaches to target emotional reactivity and self-esteem in youth to improve depressive symptom severity in a group setting across 12 weeks. We examined the preliminary feasibility, acceptability, and efficacy of CBT-DAY in a pilot non-randomized trial. In addition, we implemented a rigorous protocol for assessing, monitoring, and addressing potential harms in this intervention. Results from 24 autistic youth (11–17 years old) suggest that CBT-DAY may be feasible to use in an outpatient clinical setting and generally acceptable to youth and their caregivers. Participation in CBT-DAY may be associated with significant improvements in youth emotional reactivity and self-esteem, as well as depressive symptom severity per self-report only. Exploratory analyses showed that participation in CBT-DAY may also be associated with significant improvements in internalizing symptoms. Findings demonstrate the potential promise of neurodiversity-affirming and cognitive behavioral approaches to treating depressive symptoms in some autistic youth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vanderbilt University Medical Center, USA.
- Vanderbilt University, USA.
- Williams Baptist University, USA.
- Independent Researcher and Community Member, USA.
ORCID-Profile: Jessica M Schwartzman, Zachary J Williams
Förderung
- NCATS NIH HHS
- NIMH NIH HHS
- NIDCD NIH HHS
- NIGMS NIH HHS
- Vanderbilt Institute for Clinical and Translational Research
- National Institute of General Medical Sciences
- National Center for Advancing Translational Sciences
- National Institute for Mental Health
Zitieren
APA
Schwartzman, J. M., Roth, M. C., Paterson, A. V., Jacobs, A. X., & Williams, Z. J. (2024). Community-guided, autism-adapted group cognitive behavioral therapy for depression in autistic youth (CBT-DAY): Preliminary feasibility, acceptability, and efficacy. Autism, 28(8), 1902-1918. https://doi.org/10.1177/13623613231213543
Vancouver
Schwartzman JM, Roth MC, Paterson AV, Jacobs AX, Williams ZJ. Community-guided, autism-adapted group cognitive behavioral therapy for depression in autistic youth (CBT-DAY): Preliminary feasibility, acceptability, and efficacy. Autism. 2024;28(8):1902-1918. doi:10.1177/13623613231213543
BibTeX
@article{Schwartzman2024,
author = {Schwartzman, Jessica M and Roth, Marissa C and Paterson, Ann V and Jacobs, Alexandra X and Williams, Zachary J},
title = {Community-guided, autism-adapted group cognitive behavioral therapy for depression in autistic youth (CBT-DAY): Preliminary feasibility, acceptability, and efficacy},
journal = {Autism},
year = {2024},
volume = {28},
number = {8},
pages = {1902--1918},
doi = {10.1177/13623613231213543}
}
EUVIMED